Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF | V.TLT.WT

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by ProOrbiteon Jun 21, 2017 10:35am
334 Views
Post# 26387100

A picture is worth a thousand words!

A picture is worth a thousand words!
If you take a close look at the  picture from the baldder wall in the the dosimetry pannning news release it is very informative!

https://theralase.com/pressrelease/theralase-presents-dosimetry-planning-at-international-world-congress/

"Photographic data demonstrating how TLD-1433 had the ability to localize specifically to human bladder cancer tumours during the Phase Ib NMIBC clinical study, staining them yellowish after a sixty minute intravesical installation, while leaving healthy bladder urothelium untouched."

Here are my points that I can see from that picture!

1)These microcell clusters do no appear to be scrapped or any area near that picture is scrapped and or inflamed! So it is a differnet area where the scrapping took place.

2) New microcell clusters that are seperate from the central yellow cell cluster have been missed!. After scrapping known clusters they probably did not see this cluster.  But they knew that would happen but decided to empahsize that CLEARLY in this picture with the staining.

3) These microcell clusters and central yellow cell cluster are stained yellow even at Half dosage!

"The clinical data for the initial three patients treated in the Study with the recommended starting dose of TLD-1433 PDC (0.35 mg/cm2)"

4) So if these cancer cells are stained yellow and the TLD-1433 was activated within the balder. You can rightfully assume that these cancer cells have been obliterated! With all know studies that they have already done. 

"Target Light Radiant Exposure (“Dose”) of 90 J/cm2 (+/- 20%) was achieved in the first 3 patients based on 6 light dose sensors."

5) These cancer cells since being obliterated would probably cause some discomfort to the patient if this is all over their bladder walls. But it takes 1 to 2 weeks for a a deep scrapped/damaged skin to heal! So thats why "the only Adverse Events (“AEs”) reported during that period were mild or moderate in nature, and hence not clinically significant, with over 80% of them (9/11) completely resolved within 21 days of treatment." Dont forget how narrow the Eurethra is and they have to shove this device up it. Which also would stretch and  possibly cause some cell wall damage within the eurethra that needs to heal.

6) Healthy blader wall was "untouched" by the proceedure!

7) There would be no point to doing a half dose if you would know that this dosage would be fruitless in destroying the cancer cells. It was agreed to this dose cause this PDC TLD 1433 is very effective an THEY KNOW THAT!

8) Testing for cancer dead cells in the urine after the proceedure is probably known. But cant release that data as of yet!

This is my opnion from what I have seen and read.

SO good luck to all!


Bullboard Posts